HLA Gene Polymorphisms in Romanian Patients with Chronic Lymphocytic Leukemia
Genetics Research · 2024
DOI: 10.1155/2024/8852876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics Research, 2024. Verfasst von Maria Tizu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Transplant Immunology, Carol Davila University of Medicine and Pharmacy, 258 Fundeni Avenue, Bucharest 022328, Romania. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives. Numerous genome-wide association studies have highlighted that chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder with an important genetic component. An important number of genes have been implicated in CLL etiology, with some of the most important being human leukocyte antigen (HLA) genes. The aim of this study was to analyze the association of CLL with certain HLA alleles in the Romanian population and to compare our results with previous findings. Materials and Methods. This study included 66 patients with CLL, diagnosed between 2020 and 2022, and 100 healthy controls. HLA class I and class II genes (HLA-A/B/C, HLA-DQA1/DQB1/DPA1/DPB1, and HLA-DRB1/3/4/5) were investigated using next-generation sequencing technology.
Results
Several HLA alleles were strongly associated with CLL. The most important finding was that HLA-DRB1 ∗ 04:02:01 ( p = 0.001 , OR = 1.05) and HLA-DRB3 ∗ 02:01:01 ( p = 0.009 , OR = 1.03) have a predisposing role in CLL development. Moreover, we identified that HLA-A ∗ 24:02:01 0.01 ( p = 0.01 , OR = 0.38), HLA-DQA1 ∗ 05:05:01 ( p = 0.01 , OR = 0.56), HLA-DQB1 ∗ 03:02:01 ( p = 0.03 , OR = 0.40), and HLA-DRB4 ∗ 01:03:01 ( p = 0.03 , OR = 0.54 alleles have protective roles. Correlations between HLA expression and gender showed that women had a higher expression of protective HLA alleles when compared to men.
Conclusions
Our data are the first to indicate that in Romanian patients with CLL, the HLA-A ∗ 24:02:01 and HLA-DQA1 ∗ 05:05:01 alleles have a protective role against CLL development, whereas HLA-DRB1 ∗ 04:02:01 and HLA-DRB3 ∗ 02:01:01alleles are positively associated with CLL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Immunology and Transplant Immunology, Carol Davila University of Medicine and Pharmacy, 258 Fundeni Avenue, Bucharest 022328, Romania.
- Centre of Immunogenetics and Virology, Fundeni Clinical Institute, 258 Fundeni Avenue, Bucharest 022328, Romania.
- Colentina Clinical Hospital, Rheumatology Department Bucharest, 19-21 Stefan Cel Mare Street, Bucharest 020125, Romania.
ORCID-Profile: Maria Tizu, Bogdan Calenic, Bogdan M Cristea, Ion Maruntelu, Andreea M Caragea, Adriana Talangescu, Alina Dima, Ileana Constantinescu
Zitieren
APA
Tizu, M., Calenic, B., Hârza, M., Cristea, B. M., Maruntelu, I., Caragea, A. M., Talangescu, A., Dima, A., Constantinescu, A. E., & Constantinescu, I. (2024). HLA Gene Polymorphisms in Romanian Patients with Chronic Lymphocytic Leukemia. Genetics Research. https://doi.org/10.1155/2024/8852876
Vancouver
Tizu M, Calenic B, Hârza M, Cristea BM, Maruntelu I, Caragea AM, et al. HLA Gene Polymorphisms in Romanian Patients with Chronic Lymphocytic Leukemia. Genetics Research. 2024. doi:10.1155/2024/8852876
BibTeX
@article{Tizu2024,
author = {Tizu, Maria and Calenic, Bogdan and Hârza, Mihai and Cristea, Bogdan M and Maruntelu, Ion and Caragea, Andreea M and Talangescu, Adriana and Dima, Alina and Constantinescu, Alexandra E and Constantinescu, Ileana},
title = {HLA Gene Polymorphisms in Romanian Patients with Chronic Lymphocytic Leukemia},
journal = {Genetics Research},
year = {2024},
doi = {10.1155/2024/8852876}
}
EUVIMED